Q2 2026 Holdings
Filed 2026-08-14 | 16 holdings | $287.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $34.0M | 950,011 | 11.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $32.9M | 1,029,298 | 11.4% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $29.9M | 4,056,379 | 10.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $27.6M | 797,600 | 9.6% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $25.6M | 5,869,091 | 8.9% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $22.8M | 2,353,304 | 7.9% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $20.9M | 606,660 | 7.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $19.1M | 3,947,913 | 6.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $18.5M | 497,270 | 6.4% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $15.0M | 1,050,000 | 5.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $11.0M | 738,972 | 3.8% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $7.0M | 271,250 | 2.4% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $6.7M | 9,681,763 | 2.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.3M | 3,057,325 | 2.2% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.2M | 1,369,782 | 1.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $5.2M | 476,200 | 1.8% |